INS and Hypoglycemia: In patients for whom hypoglycaemia is a concern, FPG should be maintained at ≥100 mg/dl (5.6 mmol/L)37 based on the ‘Treat‐to‐Target’ paradigm of dose adjustments to make insulin therapy simpler for patients and clinicians alike.